OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
Rhea-AI Summary
OPKO Health (NASDAQ:OPK) announced its participation in the upcoming 3rd Annual Piper Sandler Virtual Obesity Symposium on June 26, 2025. The company's management will engage in a fireside discussion moderated by Edward Tentoff, Managing Director and Senior Biotechnology Analyst at Piper Sandler. Interested investors can register for the virtual event through their Piper Sandler representatives.
Positive
- None.
Negative
- None.
News Market Reaction – OPK
In the trading session that priced this news, OPK declined 1.55%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fireside discussion moderated by Edward Tentoff, Managing Director, Senior Biotechnology Analyst. Investors can register for the symposium by contacting their Piper Sandler representative.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
